← Leaderboards
Steven Herbert Abman
Johns Hopkins University
$28,175,515
Attributed
$41,953,498
Total exposure
17
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$41,953,498 · 17
By mechanism
R01$13,143,351 · 3
U01$11,460,868 · 3
T32$7,392,086 · 2
UH3$3,169,398 · 1
P50$2,332,677 · 3
R38$2,225,134 · 1
Top collaborators
- Kenneth D Mandl7 shared
- Peter Buttrick6 shared
- David Albert Schwartz6 shared
- Eric Douglas Austin4 shared
- Erika S. Berman-Rosenzweig4 shared
- Jorge A Dipaola4 shared
- Jeffrey R Fineman4 shared
- Lewis H Romer4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Kannan Rangaramanujam$10,355,612
- Marlene Rosemary Miller$3,314,013
Others in their field
Top investigators on “Childhood”
- Gregory H Reaman · National Childhood Cancer Foundation$268,060,146
- Barbara Driver · Westat, Inc.$206,410,885
- Sharon A Nachman · Johns Hopkins University$191,166,598
- Peter C Adamson · National Childhood Cancer Foundation$190,988,407
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- James E. Gern · University Of Wisconsin-Madison$149,875,125
Research focus
ChildhoodLungLung DiseasesBasePulmonary HypertensionBronchopulmonary DysplasiaClinical ResearchMorbidity - Disease RateAdultStructureProgramsVascular DiseasesChildMedicineEducational WorkshopBlood VesselsPerinatalUniversitiesInfantGrowthVascular Endothelial Growth FactorsMultidisciplinaryTraining ProgramsLife
Grant awards (89)
1/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy In Pediatric Pulmonary Arterial Hypertension$652,233
UH3 · FY2025 · HL
Colorado StARR Program (CSP)$426,349
R38 · FY2025 · HL
Multidisciplinary Research Training in Pediatric Pulmonary Vascular Disease$366,737
T32 · FY2025 · HL
1/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy In Pediatric Pulmonary Arterial Hypertension$1,218,226
UH3 · FY2024 · HL
Colorado StARR Program (CSP)$426,349
R38 · FY2024 · HL
Multidisciplinary Research Training in Pediatric Pulmonary Vascular Disease$387,294
T32 · FY2024 · HL
1/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy In Pediatric Pulmonary Arterial Hypertension$1,298,939
UH3 · FY2023 · HL
Multidisciplinary Research Training in Pediatric Pulmonary Vascular Disease$376,328
T32 · FY2023 · HL
Colorado StARR Program in Medicine and Pediatrics (CSPMP)$343,109
R38 · FY2023 · HL
Physiological Phenotyping of Respiratory Outcomes in Infants Born Premature$748,521
R01 · FY2022 · HL
Multidisciplinary Research Training in Pediatric Pulmonary Vascular Disease$358,400
T32 · FY2022 · HL
Colorado StARR Program in Medicine and Pediatrics (CSPMP)$343,109
R38 · FY2022 · HL
1/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy In Pediatric Pulmonary Arterial Hypertension$952,595
UG3 · FY2021 · HL
Physiological Phenotyping of Respiratory Outcomes in Infants Born Premature$763,145
R01 · FY2021 · HL
Role of VEGF in Perinatal Hypertension$662,785
R01 · FY2021 · HL · contact PI
Colorado StARR Program in Medicine and Pediatrics (CSPMP)$343,109
R38 · FY2021 · HL
Physiological Phenotyping of Respiratory Outcomes in Infants Born Premature$772,748
R01 · FY2020 · HL
Role of VEGF in Perinatal Hypertension$670,560
R01 · FY2020 · HL · contact PI
Colorado StARR Program in Medicine and Pediatrics (CSPMP)$343,109
R38 · FY2020 · HL
Physiological Phenotyping of Respiratory Outcomes in Infants Born Premature$795,053
R01 · FY2019 · HL
Role of VEGF in Perinatal Hypertension$665,895
R01 · FY2019 · HL · contact PI
Academic Training Program in Pediatric Pulmonary Disease$221,162
T32 · FY2019 · HL · contact PI
Academic Training in Cardiopulmonary Disease in Down Syndrome$160,718
T32 · FY2019 · HL · contact PI
Role of VEGF in Perinatal Hypertension$764,637
R56 · FY2018 · HL · contact PI
Data Fusion: A Sustainable, Scalable, Open Source Registry Advancing PVD Research$512,401
U01 · FY2018 · HL · contact PI
Data Fusion: A Sustainable, Scalable, Open Source Registry Advancing PVD Research$406,307
U01 · FY2018 · HL · contact PI
Academic Training Program in Pediatric Pulmonary Disease$304,097
T32 · FY2018 · HL · contact PI
Data Fusion: A Sustainable, Scalable, Open Source Registry Advancing PVD Research$2,187,208
U01 · FY2017 · HL · contact PI
Academic Training Program in Pediatric Pulmonary Disease$265,877
T32 · FY2017 · HL · contact PI
Data Fusion: A Sustainable, Scalable, Open Source Registry Advancing PVD Research$2,178,598
U01 · FY2016 · HL · contact PI
Academic Training Program in Pediatric Pulmonary Disease$452,075
T32 · FY2016 · HL · contact PI
Data Fusion: A Sustainable, Scalable, Open Source Registry Advancing PVD Research$1,759,017
U01 · FY2015 · HL · contact PI
Academic Training Program in Pediatric Pulmonary Disease$433,892
T32 · FY2015 · HL · contact PI
Data Fusion: A Sustainable, Scalable, Open Source Registry Advancing PVD Research$428,492
U01 · FY2015 · HL · contact PI
Role of VEGF in Perinatal Hypertension$392,009
R01 · FY2015 · HL · contact PI
Pediatric Pulmonology and Hematology Research Training for Medical Students$1,281
T35 · FY2015 · HL · contact PI
Data Fusion: A Sustainable, Scalable, Open Source Registry Advancing PVD Research$1,785,835
U01 · FY2014 · HL · contact PI
Role of VEGF in Perinatal Hypertension$389,507
R01 · FY2014 · HL · contact PI
Pediatric Pulmonology and Hematology Research Training for Medical Students$15,555
T35 · FY2014 · HL · contact PI
Role of VEGF in Perinatal Hypertension$379,313
R01 · FY2013 · HL · contact PI
Academic Training Program in Pediatric Pulmonary Disease$142,515
T32 · FY2013 · HL · contact PI
Pediatric Pulmonology and Hematology Research Training for Medical Students$24,935
T35 · FY2013 · HL · contact PI
Genetic Basis for Impaired Angiogenic Signaling in BPD$634,578
R01 · FY2012 · HL · contact PI
Role of VEGF in Perinatal Hypertension$420,655
R01 · FY2012 · HL · contact PI
Academic Training Program in Pediatric Pulmonary Disease$394,508
T32 · FY2012 · HL · contact PI
Pediatric Pulmonology and Hematology Research Training for Medical Students$24,935
T35 · FY2012 · HL · contact PI
Genetic Basis for Impaired Angiogenic Signaling in BPD$642,927
R01 · FY2011 · HL · contact PI
Academic Training Program in Pediatric Pulmonary Disease$406,413
T32 · FY2011 · HL · contact PI
CORE--Clinical Research Skills Development$64,849
P50 · FY2011 · HL · contact PI
Phase II Trial of Sildenafil in Newborns with Persistent Pulmonary Hyptertension$1,293,473
U01 · FY2010 · HL
Genetic Basis for Impaired Angiogenic Signaling in BPD$654,392
R01 · FY2010 · HL · contact PI
Role of VEGF in Perinatal Pulmonary Hypertension$412,038
R01 · FY2010 · HL · contact PI
CORE--Clinical Research Skills Development$101,326
P50 · FY2010 · HL · contact PI
Academic Training Program in Pediatric Pulmonary Disease$80,540
T32 · FY2010 · HL · contact PI
Genetic Basis for Impaired Angiogenic Signaling in BPD$675,344
R01 · FY2009 · HL · contact PI
Role of VEGF in Perinatal Pulmonary Hypertension$415,846
R01 · FY2009 · HL · contact PI
CORE--Clinical Research Skills Development$101,437
P50 · FY2009 · HL · contact PI
Academic Training Program in Pediatric Pulmonary Disease$80,629
T32 · FY2009 · HL · contact PI
Genetic Basis for Impaired Angiogenic Signaling in BPD$730,135
R01 · FY2008 · HL · contact PI
Role of VEGF in Perinatal Pulmonary Hypertension$411,352
R01 · FY2008 · HL · contact PI
Academic Training Program in Pediatric Pulmonary Disease$376,419
T32 · FY2008 · HL · contact PI
CLINICAL CORE$222,511
U01 · FY2008 · HL · contact PI
CORE--Clinical Research Skills Development$100,515
P50 · FY2008 · HL · contact PI
Role of VEGF in Perinatal Pulmonary Hypertension$396,548
R01 · FY2007 · HL · contact PI
Academic Training Program in Pediatric Pulmonary Disease$376,419
T32 · FY2007 · HL · contact PI
CLINICAL CORE$227,054
U01 · FY2007 · HL · contact PI
CORE--Clinical Research Skills Development$111,881
P50 · FY2007 · HL · contact PI
Project II$391,625
P50 · FY2006 · HL · contact PI
Academic Training Program in Pediatric Pulmonary Disease$376,419
T32 · FY2006 · HL · contact PI
CLINICAL CORE$226,736
U01 · FY2006 · HL · contact PI
Project II$383,770
P50 · FY2005 · HL
Academic Training Program in Pediatric Pulmonary Disease$353,597
T32 · FY2005 · HL
CLINICAL CORE$233,236
U01 · FY2005 · HL
Vasculogenesis failure in neonatal pulmonary hypertension$232,637
P01 · FY2005 · HL
Role of VEGF in Perinatal Pulmonary Hypertension$377,500
R01 · FY2004 · HL
Project II$374,716
P50 · FY2004 · HL
Academic Training Program in Pediatric Pulmonary Disease$374,411
T32 · FY2004 · HL
Role of VEGF in Perinatal Pulmonary Hypertension$377,500
R01 · FY2003 · HL
ACADEMIC TRAINING PROGRAM IN PEDIATRIC PULMONARY DISEASE$1
T32 · FY2003 · HL
ACADEMIC TRAINING PROGRAM IN PEDIATRIC PULMONARY DISEASE$396,023
T32 · FY2002 · HL
Role of VEGF in Perinatal Pulmonary Hypertension$377,500
R01 · FY2002 · HL
Vasculogenesis failure in neonatal pulmonary hypertension$213,409
P01 · FY2002 · HL
NITRIC OXIDE/CYCLIC GMP CASCADE IN NEONATAL PULMONARY HYPERTENSION$208,827
P50 · FY2002 · HL
Role of VEGF in Perinatal Pulmonary Hypertension$377,500
R01 · FY2001 · HL
ACADEMIC TRAINING PROGRAM IN PEDIATRIC PULMONARY DISEASE$362,945
T32 · FY2001 · HL
NITRIC OXIDE/CYCLIC GMP CASCADE IN NEONATAL PULMONARY HYPERTENSION$208,827
P50 · FY2001 · HL
Vasculogenesis failure in neonatal pulmonary hypertension$0
P01 · FY2001 · HL
ACADEMIC TRAINING PROGRAM IN PEDIATRIC PULMONARY DISEASE$344,667
T32 · FY2000 · HL
NITRIC OXIDE/CYCLIC GMP CASCADE IN NEONATAL PULMONARY HYPERTENSION$284,904
P50 · FY2000 · HL